Hydrophilic membranes

Information

  • Patent Grant
  • 8524794
  • Patent Number
    8,524,794
  • Date Filed
    Monday, July 4, 2005
    18 years ago
  • Date Issued
    Tuesday, September 3, 2013
    10 years ago
Abstract
A method of coating a polymer comprising the step of treating the polymer with an activating agent to produce a reactive polymer, for example treating a polymer bearing at least one X (halogen) group and at least one H with base to eliminate HX. The reactive polymer is then reacted with a reactive coating, for example PVP, preferably in the presence of an initiator like persulfate anions, to produce a coated polymer, which may be hydrophilic in nature.
Description
TECHNICAL FIELD

The invention relates to polymeric membranes having a hydrophilic layer grafted to the surface thereof and to methods for the preparation of such membranes. The invention particularly relates to the field of ultrafiltration and microfiltration.


BACKGROUND ART

The following discussion is not to be construed as an admission with regard to the state of the common general knowledge.


Synthetic polymeric membranes are well known in the field of ultrafiltration and microfiltration for a variety of applications including desalination, gas separation, filtration and dialysis. The properties of the membranes vary depending on the morphology of the membrane i.e. properties such as symmetry, pore shape, pore size and the chemical nature of the polymeric material used to form the membrane.


Different membranes can be used for specific separation processes, including microfiltration, ultrafiltration and reverse osmosis. Microfiltration and ultrafiltration are pressure driven processes and are distinguished by the size of the particle or molecule that the membrane is capable of retaining or passing. Microfiltration can remove very fine colloidal particles in the micrometer and submicrometer range. As a general rule, microfiltration can filter particles down to 0.05 μm, whereas ultrafiltration can retain particles as small as 0.01 μm and smaller. Reverse Osmosis operates on an even smaller scale.


Microporous phase inversion membranes are particularly well suited to the application of removal of viruses and bacteria.


A large surface area is needed when a large filtrate flow is required. A commonly used technique to minimize the size of the apparatus used is to form a membrane in the shape of a hollow porous fibre. A large number of these hollow fibres (up to several thousand) are bundled together and housed in modules. The fibres act in parallel to filter a solution for purification, generally water, which flows in contact with the outer surface of all the fibres in the module. By applying pressure, the water is forced into the central channel, or lumen, of each of the fibres while the microcontaminants remain trapped outside the fibres. The filtered water collects inside the fibres and is drawn off through the ends.


The fibre module configuration is a highly desirable one as it enables the modules to achieve a very high surface area per unit volume.


In addition to the arrangement of fibres in a module, it is also necessary for the polymeric fibres themselves to possess the appropriate microstructure to allow microfiltration to occur.


Desirably, the microstructure of ultrafiltration and microfiltration membranes is asymmetric, that is, the pore size gradient across the membrane is not homogeneous, but rather varies in relation to the cross-sectional distance within the membrane. Hollow fibre membranes are preferably asymmetric membranes possessing tightly bunched small pores on one or both outer surfaces and larger more open pores towards the inside edge of the membrane wall.


This microstructure has been found to be advantageous as it provides a good balance between mechanical strength and filtration efficiency.


As well as the microstructure, the chemical properties of the membrane are also important. The hydrophilic or hydrophobic nature of a membrane is one such important property.


Hydrophobic surfaces are defined as “water hating” and hydrophilic surfaces as “water loving”. Many of the polymers used to cast porous membranes are hydrophobic polymers. Water can be forced through a hydrophobic membrane by use of sufficient pressure, but the pressure needed is very high (150-300 psi), and a membrane may be damaged at such pressures and generally does not become wetted evenly.


Hydrophobic microporous membranes are typically characterised by their excellent chemical resistance, biocompatibility, low swelling and good separation performance. Thus, when used in water filtration applications, hydrophobic membranes need to be hydrophilised or “wet out” to allow water permeation.


It is also important that membranes have a high resistance to aggressive chemical species typically found in water requiring filtration, in particular, to oxidising agents and conditions of high pH (i.e. caustic solutions). In particular with water filtration membranes, chlorine resistance is highly desirable. Chlorine is used to kill bacteria and is invariably present in town water supplies. Even at low concentrations, a high throughput of chlorinated water can expose membranes to large amounts of chlorine over the working life of a membrane can lead to yellowing or brittleness which are signs of degradation of the membrane.


Currently, poly(tetrafluoroethylene) (PTFE), polyethylene (PE), polypropylene (PP) and poly(vinylidene fluoride) (PVDF) are the most popular and available hydrophobic membrane materials. However, the search for membrane materials which will provide better chemical stability and performance while retaining the desired physical properties required to allow the membranes to be formed and worked in an appropriate manner has suggested that halogentated polymers may be suitable. In particular, Halar ultrafiltration (UF) membranes have been found to be superior in nearly every way to any unsupported hollow-fibre UF membrane on the market.


Microporous synthetic membranes are particularly suitable for use in hollow fibres and are produced by phase inversion. In this process, at least one polymer is dissolved in an appropriate solvent and a suitable viscosity of the solution is achieved. The polymer solution can be cast as a film or hollow fibre, and then immersed in precipitation bath such as water. This causes separation of the homogeneous polymer solution into a solid polymer and liquid solvent phase. The precipitated polymer forms a porous structure containing a network of uniform pores. Production parameters that affect the membrane structure and properties include the polymer concentration, the precipitation media and temperature and the amount of solvent and non-solvent in the polymer solution. These factors can be varied to produce microporous membranes with a large range of pore sizes (from less than 0.1 to 20 μm), and possess a variety of chemical, thermal and mechanical properties.


Hollow fibre ultrafiltration and microfiltration membranes are generally produced by either diffusion induced phase separation (the DIPS process) or by thermally induced phase separation (the TIPS process).


The TIPS process is described in more detail in PCT AU94/00198 (WO 94/17204) AU 653528, the contents of which are incorporated herein by reference.


The quickest procedure for forming a microporous system is thermal precipitation of a two component mixture, in which the solution is formed by dissolving a thermoplastic polymer in a solvent which will dissolve the polymer at an elevated temperature but will not do so at lower temperatures. Such a solvent is often called a latent solvent for the polymer. The solution is cooled and, at a specific temperature which depends upon the rate of cooling, phase separation occurs and the polymer rich phase separates from the solvent.


The term “solvent” as used herein will be understood by those in the art to encompass: single component mixtures and multiple component mixtures. Multiple component mixtures may include, in addition to solvent components, one or more non-solvents.


In the present case the inventors have sought to find a way to modify polymers and polymeric membranes made from halogenated polymers to enhance the range of applications in which they may be used, while at the same time, retaining the good intrinsic resistance of the material to chemical, physical and mechanical degradation. One such polymer is halar.


Halar, or poly (ethylene chlorotrifluoroethylene), is a 1:1 alternating copolymer of ethylene and chlorotrifluoroethylene with the following structure:

—(—CH2—CH2—CFCl—CF2—)n


Halar and related membranes have extremely good chemical resistance to species such as chlorine, peroxide and ozone, and are stable over a wide range of pHs (0-14)


Processes used to produce flat sheet Halar membranes are disclosed for example in U.S. Pat. No. 4,702,836. The properties of Halar make it highly desirable in the field of ultrafiltration and microfiltration. In particular, Halar has extremely good properties in relation to its resistance both to chlorine and to caustic solutions, but also to ozone and other strong oxidising agents.


Halar membranes also have good mechanical and structural properties. Halar produces membranes of near-perfect sub-structure, with little or no defects or macrovoids. Good permeabilities, in the range of 300-1000 lmh/bar can be achieved. Halar membranes, particularly hollow fibre membranes, have a good break extension, of greater than 100%, a break force in excess of 2N and exhibit high flexibility with little or no brittleness.


As a result of this good integrity, Halar membranes have been able to achieve log virus retentions (LRV) of ≧4, ie better than 1 in 10,000 viral particles removed.


However, Halar and related membranes are not without some drawbacks. They have a tendency to exhibit reasonable performance initially, but after a relatively short time in use, can suffer from irreversible fouling, pore-compaction or both.


In the present case the inventors have sought to find a way to modify polymers and polymeric membranes made from halogenated polymer such as Halar to enhance the range of applications in which they may be used, while at the same time, retaining the good intrinsic resistance of the material to chemical, physical and mechanical degradation. The most desirable modification is to render the material hydrophilic.


Hydrophilisation of membranes with agents such as PVP has been attempted previously. U.S. Pat. Nos. 5,376,274 and 5,629,084 both disclose coating a polysulfone membrane with a PVP/initiator (persulfate) solution and then heating the soaked membrane to crosslink the PVP. This was successful in converting the hydrophobic membrane into a hydrophilic one to improve the wettability of the membrane for filtering aqueous solutions. However, the treatment is of a very short term nature and only a minor increase in the time to irreversible fouling is realised.


Halar, because of its very inertness, is not readily amendable to functionalisation or chemical modification, and for this reason, has not been used as widely as some other membrane forming polymers which are less resistant to environmental degradation. Attempts to hydrophilise Halar in the past have proved difficult for this very reason.


One approach to hydrophilising halar membranes carried out by the present applicant has been to remove HCl from the polymer by exposure to aqueous solutions of alkali earth hydroxides or alkoxides, such as caustic soda or sodium methoxide to produce an activated form of halar possessing double bonds at the surface of the polymer. The activated halar is then treated with an oxidising agent, such Fenton's reagent, which acts as a source of hydroxyl radicals. The hydroxyl radicals react with the double bonds to produce a hydroxylated form of halar which is more hydrophilic than unmodified halar. This is disclosed in AU 2004903680, the contents of which is incorporated by reference in its entirety in the present application. This hydroxylated form of halar is also more amenable to reaction with other chemical species. However, alternative approaches for the long term hydrophilisation of hydrophobic membranes are still desirable.


It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative, particularly in terms of methods of production.


Unless the context clearly requires otherwise, throughout the description and the claims, the words ‘comprise’, ‘comprising’, and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to”.







DESCRIPTION OF THE INVENTION

According to a first aspect, the invention provides a method of coating a polymer comprising the step of treating said polymer with an activating agent to produce a reactive polymer, and reacting said reactive polymer with a reactive coating to produce a coated polymer.


Preferably, the polymer bears at least one X group, where X is F or Cl, and at least one H.


The polymer which bears at least one X group may be a wholly or partially halogenated homopolymer, copolymer or terpolymer, one or more wholly or partially halogenated homopolymers, copolymers or terpolymers, or a blend of one or more wholly or partially halogenated homopolymers, copolymers or terpolymers with any miscible non-halogenated polymer, polymer blend or polymer mixture.


Preferably, the polymer has at least one X (halogen) bonded to a carbon in a position a to a hydrogen, that is, it is preferred if the X and the H are on adjacent carbon atoms.


Specific examples of halogenated polymers suitable for use in the present invention are PVdF (poly vinylidene fluoride) homopolymer, for example Kynar® or Solef®, Ethylene-chlorotrifluoroethylene copolymer (Halar) or Ethylene-chlorotrifluoroethylene terpolymer with n-butyl acrylate; terpolymers of Vinyl Fluoride/Chloride; Vinylidene Fluoride/Chloride; Hexafluoropropylene, Chlorotrifluoroethlyene, Tetrafluoroethylene.


Most preferably, the polymer is halar, or poly (ethylene chlorotrifluoroethylene), a 1:1 alternating copolymer of ethylene and chlorotrifluoroethylene, and having the following structure:

—(—CH2—CH2—CFCl—CF2—)n


Alternatively, any polymer resistant to base attack containing or formed from and miscible with one or more of the following monomers may be used: chlorotrifluoroethylene vinyl fluoride, vinyl chloride; vinylidene fluoride/vinylidene chloride; hexafluoropropylene, chlorotrifluoroethlyene, tetrafluoroethylene.


Preferably, the activating agent acts to removes HX from the polymer to produce a reactive polymer. Preferably, the activating agent is a base.


Preferably the base is an alkali earth hydroxide, more particularly sodium, potassium, lithium or calcium hydroxide. Alternatively, the base may be an alkali metal alkoxide, such as sodium methoxide, sodium ethoxide, sodium propoxide, potassium methoxide, potassium ethoxide, potassium propoxide and the like. As a further alternative, a strong amine base maybe used, such as tetraethylene pentamine.


Preferably, once in its reactive form, the polymer bears a double bond.


Preferably the reactive coating is a hydrophilic polymer. Most preferably, the reactive coating is PVP.


Preferably, the reactive coating is reacted to the reactive polymer in the presence of an initiator. One preferred initiator is persulfate, (S2O82−). Preferably the persulfate is in the form of potassium persulfate, ammonium persulfate, sodium di-persulfate or sodium mono-persulfate.


According to a second aspect, the invention provides a method of hydrophilising a polymer comprising the step of, where applicable modifying the polymer to incorporate a cross linkable functionality and treating said polymer containing a cross linkable functionality with a cross linkable hydrophilising agent, and applying cross linking conditions.


Alternatively, a reactive coating in can be applied to a polymer naturally bearing a cross linkable functionality in the presence of an initiator to hydrophilise the polymer.


Preferably the crosslinkable functionality is a double bond


Preferably the crosslinkable hydrophilising agent is PVP.


Preferably the cross linking conditions involve the use of an initiator and/or cross linking radiation. A preferred initiator is persulfate.


According to a third aspect, the invention provides a method of hydrophilising a halar microfiltration or ultrafiltration membrane comprising the steps of:

  • i) treating said halar microfiltration or ultrafiltration membrane with a base to eliminate HCl and produce a base treated polymer; and
  • ii) treating said base treated polymer with PVP in the presence of a cross linking initiator to produce a halar microfiltration or ultrafiltration membrane with a crosslinked surface coating of PVP.


Preferably the initiator is a persulfate anion.


According to a fourth aspect the invention provides a halar microfiltration or ultrafiltration membrane with a crosslinked surface coating of PVP.


Preferably, the membranes of the present invention are asymmetric membranes, which have a large pore face and a small pore face, and a pore size gradient which runs across the membrane cross section. The membranes may be flat sheet, or more preferably, hollow fibre membranes.


According to a fifth aspect, the invention provides a functionalised membrane prepared according to the present invention for use in the microfiltration and ultrafiltration of water and wastewater.


According to a sixth aspect, the invention provides a functionalised membrane prepared according to the present invention for use as an affinity membrane.


According to a seventh aspect, the invention provides a functionalised membrane prepared according to the present invention for use as protein adsorption.


According to an eighth aspect, the invention provides a functionalised membrane prepared according to the present invention for use in processes requiring bio-compatible functionalised membranes.


BEST METHOD OF PERFORMING THE INVENTION

The present invention is disclosed herein with respect to polymeric ultrafiltration membranes or microfiltration membranes. However, it will be appreciated by those skilled in the art that the method can be applied to any appropriate polymeric material where modifications of the kind described are desirable. Any article prepared from a suitable polymer may be hydrophilised in accordance with the present invention.


As mentioned above, the present invention can be carried out upon any polymeric microfiltration or ultrafiltration membrane which bears at least one X group; and may be a wholly or partially halogenated homopolymer, copolymer or terpolymer, one or more wholly or partially halogenated homopolymers, copolymers or terpolymers, or a blend of one or more wholly or partially halogenated homopolymers, copolymers or terpolymers with any miscible non-halogenated polymer, polymer blend or polymer mixture.


Specific examples of halogenated polymers suitable for use in the present invention are PVdF (poly vinylidene fluoride) homopolymer, for example Kynar®, Solef®, Ethylene-chlorotrifluoroethylene copolymer (Halar) or Ethylene-chlorotrifluoroethylene terpolymer with n-butyl acrylate (Halar XPM2); terpolymers of Vinyl Fluoride/Chloride; Vinylidene Fluoride/Chloride; Hexafluoropropylene, Chlorotrifluoroethlyene, Tetrafluoroethylene.


The present invention will be described with particular reference to halar, the most preferred compound of the present invention. Halar is a 1:1 alternating copolymer of ethylene-chlorotrifluoroethylene copolymer.

—(CH2CH2—CCl2—CClF)n


Halar membranes in the form of hollow fibres were prepared according to the method disclosed in PCT AU94/00198 (WO 94/17204) and AU 653528, the contents of which are incorporated herein by reference. Halar membranes used in the experiment were either microfiltration (MF) membranes (nominal pore size=0.1 μm) or ultrafiltration (UF) membranes (nominal pore size=0.01 μm). The polymer, halar, used for both membrane types was identical.


A halar membrane with PVP bound to the surface was prepared. In order to do this, opportunities for a reaction between PVP and otherwise inert halar polymer first needed to be created. The first step in the process was carried out by treatment of halar with a concentrated solution of sodium hydroxide to generate double bonds (via dehydrohalogenation) on the membrane surface that can react with radicals.


The elimination of HX, which in the case of halar is HCl, was more specifically carried out by treating a preformed polymeric ultrafiltration or microfiltration membrane with a 20 wt % caustic solution at 80-120° C. for a period of between 30 minutes and 4 hours. The membrane was then removed from the caustic solution and rinsed with water for 1-2 hours, until the pH of the solution was neutral. The fibres underwent a colour change from white to dark beige/brown during the caustic treatment, known from experience to be evidence that double bonds are forming.


The effect of the length of exposure to caustic solution was investigated and it was established that fibres treated for two hours or longer in caustic were wetting in water after post treatment.


The conditions for successful modification of the halar membrane were found to be unexpectedly mild. Halar UF membranes could be successfully made hydrophilic by initial treatment of the membrane with 30 wt % caustic at 40° C. for 168 hrs (7 days), followed by a treatment of the membrane with PVP at 40° C. for 2 hours. The reaction was accelerated by using higher temperatures, but the permeability was detrimentally affected in the case of UF membranes.


Once the caustic treatment was performed, the membrane is then allowed to react with PVP and free radicals arising from an initiator such as persulfate.


Modified membranes prepared according to the present invention suffer minimal loss of properties. Hydraulic/mechanical properties and chemical resistance appear largely unaffected. Initial non-optimised samples tested for Virus rejection gave LRV >3.5.


In use, halar membranes are likely to be exposed to high concentrations of oxidisers like chlorine and ozone. These oxidising agents can provide satisfactory cleaning of the membrane well but are also known to degrade PVP, and can eliminate any advantage in those prior art systems where the PVP is not bound to the membrane.


Binding the coating to the membrane surface in accordance with the present invention improves the resistance of the hydrophilic layer to oxidation. Even when the coating is partially oxidised, it appears that fragments of hydrophilising polymer remain bound to the surface, beneficially affecting the anti-fouling characteristic of the membrane.


Experimental, Results & Discussion


All of the experiments had the same general procedure of caustic treatment with subsequent surface modification as set out below. All percentages are by weight.


1. Wetting with ethanol (if fibres are not already stored in water) (0.5 hr)


2. Water wash (0.5 hr)


3. Soak in concentrated NaOH solution (0.5 hr)


4. NaOH treatment at elevated temperature for various lengths of time


5. Water wash (2-3 hrs)


6. Soak in PVP/Persulfate solution (1-2 hr)


7. Treatment at elevated temperature (1-2 hr) in 100% humid atmosphere


8. Water wash (>2 hrs)


9. Soak in 20% Glycerol


MF Fibres


The reactions were initially carried out on microfiltration membranes with a pore size of 0.1 μm. Samples were exposed to a 20% caustic solution at a temperature of 90° C. for 21 hrs (overnight). The treatment was otherwise as above with the exception that all fibres were washed in ethanol for 3 hrs immediately after treatment with persulfate.


Control #1 was a completely untreated sample. Control #2 was a sample exposed only to the persulfate treatment only. Control #3 had no PVP included; the persulfate treatment consisted of initiator alone.


Membrane samples were initially white and turned brown on caustic treatment. Treatment with persulfate/PVP treatment caused a colour change from brown to light beige.









TABLE 1







MF Experiments















Control
Control
Control







#1
#2
#3
a
b
c
d


















OD
650
650
650
650
650
650
650


ID
310
310
310
310
310
310
310


NaOH %


20
20
20
20
20


Oven temp (° C.)


90
90
90
90
90


Time in Caustic


18
18
18
18
18


(hr)


Persulfate (%)

5
5
5
5
5
5


H2SO4 (%)

0.1
0.1
0.1
0.1
0.1
0.1


PVP (%)

0.5

1
0.5
0.35
0.1


PVP-VA (%)

0.5

1
0.5
0.35
0.1


Total Modifier (%)

1
0
2
1
0.7
0.2


Time in

18
18
18
18
18
18


Persulfate (hr)


Oven temp (° C.)

90
90
90
90
90
90


Time in Oven

2
2
2
2
2
2


(hr)


Time Washing

4
4
4
4
4
4


(hr)


Hydrophilic
N
N
N
Y
Y
Y
Y


(Y/N)?


Permeability
1487
0
0
517
1565
1473
1932


(lmh/bar)









The permeability of the samples was evaluated as-is. Apart from control 1, which was wet with ethanol, the samples were wet only with water.


All samples treated with both caustic and PVP/Persulfate became clearly hydrophilic, as a permeability for treated samples could be obtained.


Given that the permeability of the samples with a PVP or PVP/VA concentration of ≦1% (b-d) have a permeability at least equal to the untreated sample (Control #1), the MF membrane porosity is affected by concentrations greater than this. The permeability of the membrane with the lowest concentration of PVP (d) is also similar to the control. This indicates that concentrations as low as 0.2% PVP are sufficient to impart hydrophilicity to the membrane.


It is clear from Control #3 that the absence of PVP prevents the membrane from becoming hydrophilic, despite receiving an otherwise identical treatment. Thus it can be concluded that the PVP is required to generate hydrophilicity.


Surprisingly however, Control #2 was not hydrophilic. This suggests that at least for Halar membranes, it is necessary to graft the PVP to the membrane for any permanency of the treatment. Even if the treatment had caused a hydrophilic coating of the membrane, washing the membranes with ethanol may be the reason for the apparent lack of hydrophilicity in the test. Any unbound PVP would wash away in ethanol, particularly in these low concentrations (0.5%).


These experiments were repeated successfully with various different types of PVP. A number of types of PVP, including K15, K30, K90, K120 and PVP-VA (S630) successfully produced a hydrophilic fibre, a with similar results.


However PVP K15 produced the best results in terms of minimal gel formation and evenness of coverage. K15 can be dissolved into water relatively easily without clumping, and does not greatly affect the viscosity of the solution.


UF Fibres


Once it was established from MF fibres that the treatment was successful, it was applied to UF fibres which typically have even smaller pores. A number of attempts were made using identical parameters and the membranes repeatedly became hydrophilic under identical conditions to the MF fibres.


However, using the same conditions as used to successfully coat MF membranes, it was found that UF membranes lost a significant amount, up to 70 to 80%, of their inherent permeability. Without wishing to be bound by theory, it is believed that this was due to the double bond density achieved at the membrane surface being not sufficiently high. In order to increase double bond density, a variety of temperatures, times and concentrations were investigated. It was found possible, and most desirable, to increase double bond density by increasing the concentration of caustic and the contact times, rather than increasing temperature.


The shortest exposure time possible is the most economic but lower concentrations are better for mass transfer as caustic solutions become more viscous with increasing concentration. There are also safety concerns involved. Around 20% to 30% caustic at 40° C. for varying lengths of time was found to be suitable.


The remainder of the treatment was unchanged, except that the temperature at which the persulfate treatment was performed was decreased to 40° C. in line with the temperature of the caustic treatment. The details of the experiments performed are set out in table 2.









TABLE 2





UF Results























1b
1c
1e
2a
2a



Control
2
3
5
7
7

















OD
1050
1050
1050
1050
1050
1050


ID
622
622
622
622
622
622


NaOH (%)

20
20
20
30
30


Oven Temp (° C.)

40
40
40
40
40


Time in Caustic

95
120
168
72
72


(hr)


Persulfate (%)

5
5
5
5
5


H2SO4 (%)

0.1
0.1
0.1
0.1
0.1


PVP K15 (%)

0.5
0.5
0.5
0.5
0.5


Total Modifier (%)

0.5
0.5
0.5
0.5
0.5


Time in

1
1
2
1
1


Persulfate (hr)


Time in oven

1.5
1.5
1.5
1.5
1.5


(hr)


Oven temp (° C.)

40
40
40
40
40


Time (hr)

17
0.5
2
17
17


Washing


Time (hr) in

2
2
17
2
2


20% glycerol


Hydrophilic
N
N
N
N
Y
EtOH


(Y/N)?


Permeability
147
82
123
69
33
68


(lmh/bar)


% Of Ethanol permeability




49%



















2b
2b
2c
2c
2d
2d



Control
8
8
9
9
10
10


















OD
1050
1050
1050
1050
1050
1050
1050


ID
622
622
622
622
622
622
622


NaOH (%)

30
30
30
30
30
30


Oven Temp (° C.)

40
40
40
40
40
40


Time in Caustic

96
96
144
144
168
168


(hr)


Persulfate (%)

5
5
5
5
5
5


H2SO4 (%)

0.1
0.1
0.1
0.1
0.1
0.1


PVP K15 (%)

0.5
0.5
0.5
0.5
0.5
0.5


Total Modifier (%)

0.5
0.5
0.5
0.5
0.5
0.5


Time in

1
1
2
2
2
2


Persulfate (hr)


Time in oven

1.5
1.5
1.5
1.5
1.5
1.5


(hr)


Oven temp (° C.)

40
40
40
40
40
40


Time (hr)

0.5
0.5
2
2
2
2


Washing


Time (hr)in

2
2
2
2
2
2


20% glycerol


Hydrophilic
N
Y
EtOH
Y
EtOH
Y
EtOH


(Y/N)?


Permeability
147
52
82
98
121
71
80


(lmh/bar)


% Of Ethanol

64%

81%

88%


permeability









The samples that were treated with 20% caustic showed a significantly lighter colour than those treated with 30% caustic for the same period of time. This is a clear indication that the surface double bond density has increased by increasing caustic concentration.


This is also supported by the results for hydrophilicity. Samples 1a-1e received the same treatment times as 2a-2e, but the results are dramatically different. None of the series 1a-1e were hydrophilic, while the series 2a-2e had varying degrees of hydrophilicity.


The permeability of samples 2a-2e was measured before and after wetting with ethanol to assess whether any deviation was due to pore collapse or non-wetting.


Presuming the membrane had neither collapsed nor suffered from plugged pores (which should be evident in all samples) the maximum available permeability of a specific fibre sample should be related (within the normal margins of error) to the permeability after wetting thoroughly with ethanol. Therefore a relationship should be observed by plotting the % of total permeability available (ethanol wet) that was obtained by wetting with water, versus the time exposed to caustic, and in fact a very clear relationship exists between the length of time in 30% caustic and the water-wet permeability (hydrophilicity) as a proportion of the total permeability (ethanol-wet).


The longer a sample was exposed to 30% caustic at 40° C. before PVP treatment, the more hydrophilic the final membranes were. This supports the theory for increasing surface double bond density of the membrane.


Even more importantly, the permeability of sample 2e is approximately 90% of the available permeability, close enough to the available permeability of the sample (within experimental error) to be considered fully hydrophilic.


While the invention has been described with reference to particular embodiments, it will be understood by those skilled in the art that the inventive concept disclosed herein is not limited only to those specific embodiments disclosed.

Claims
  • 1. A method of making a hydrophilic asymmetric membrane comprising: forming an activated asymmetric membrane by exposing a surface of an asymmetric membrane comprising poly(ethylene chlorotrifluoroethylene) to an activating agent under conditions suitable for generating a reactive surface on the asymmetric membrane; andforming a hydrophilic asymmetric membrane by reacting a reactive coating on the surface of the activated asymmetric membrane.
  • 2. The method of claim 1, wherein forming the asymmetric membrane comprising poly(ethylene chlorotrifluoroethylene) occurs prior to forming an activated asymmetric membrane.
  • 3. The method of claim 2, wherein forming the asymmetric membrane comprises diffusion induced phase separation.
  • 4. The method of claim 2, wherein forming the asymmetric membrane comprises thermally induced phase separation.
  • 5. The method of claim 1, wherein forming a hydrophilic asymmetric membrane by reacting the reactive coating with the activated asymmetric membrane occurs in the presence of an initiator.
  • 6. The method of claim 1, wherein forming the activated asymmetric membrane occurs by exposing the surface of the asymmetric membrane with an activating agent comprising an alkali earth hydroxide.
  • 7. The method of claim 1, wherein forming the activated asymmetric membrane occurs by exposing the surface of the asymmetric membrane with an activating agent comprising an alkali metal alkoxide.
  • 8. The method of claim 1, wherein the reactive coating is polyvinylpyrrolidone.
  • 9. The method of claim 1, wherein the activating agent comprises a solution of about 20 wt % to about 30 wt % sodium hydroxide.
  • 10. The method of claim 1, wherein forming the activated asymmetric membrane by exposing the surface of the asymmetric membrane to the activating agent occurs for a length of time suitable for forming the reactive surface.
  • 11. The method of claim 1, wherein forming the activated asymmetric membrane by exposing the surface of the asymmetric membrane to the activating agent occurs at a temperature suitable for forming the reactive surface.
  • 12. The method of claim 1, wherein forming the hydrophilic asymmetric membrane by reacting the reactive coating with the activated asymmetric membrane occurs under conditions suitable for crosslinking the reactive coating to the activated asymmetric membrane.
  • 13. The method of claim 12, wherein forming the hydrophilic asymmetric membrane by reacting the reactive coating with the activated asymmetric membrane occurs for a length of time suitable for forming the hydrophilic asymmetric membrane.
  • 14. The method of claim 12, wherein forming the hydrophilic asymmetric membrane by reacting the reactive coating with the activated asymmetric membrane occurs at a temperature suitable for forming the hydrophilic asymmetric membrane.
  • 15. A hydrophilic asymmetric membrane comprising: an asymmetric membrane comprising poly(ethylene chlorotrifluoroethylene); anda hydrophilic coating comprising polyvinylpyrrolidone (PVP) crosslinked to a surface of the asymmetric membrane.
  • 16. The hydrophilic asymmetric membrane of claim 15 further comprising a nominal pore size of about 0.1 μm.
  • 17. The hydrophilic asymmetric membrane of claim 15 further comprising a nominal pore size of about 0.01 μm.
  • 18. The hydrophilic asymmetric membrane of claim 15, wherein the membrane is in the form of a flat sheet membrane.
  • 19. The hydrophilic asymmetric membrane of claim 15, wherein the membrane is in the form of a hollow fiber membrane.
Priority Claims (2)
Number Date Country Kind
2004903680 Jul 2004 AU national
2005901689 Apr 2005 AU national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/AU2005/000975 7/4/2005 WO 00 12/21/2006
Publishing Document Publishing Date Country Kind
WO2006/002479 1/12/2006 WO A
US Referenced Citations (342)
Number Name Date Kind
1994135 Horowitz Mar 1935 A
2658045 Schildknecht Nov 1953 A
3216983 Levenson Nov 1965 A
3228876 Mahon Jan 1966 A
3275554 Wagenaar Sep 1966 A
3373056 Martin Mar 1968 A
3435893 Withers Apr 1969 A
3494780 Skiens Feb 1970 A
3556305 Shorr Jan 1971 A
3625827 Wildi et al. Dec 1971 A
3654147 Levin et al. Apr 1972 A
3693406 Tobin, III Sep 1972 A
3708071 Crowley Jan 1973 A
3728256 Cooper Apr 1973 A
3864289 Rendall Feb 1975 A
3876738 Marinaccio et al. Apr 1975 A
3886066 Chen et al. May 1975 A
3968192 Hoffman, III et al. Jul 1976 A
3992301 Shippey et al. Nov 1976 A
3993816 Baudet et al. Nov 1976 A
4033817 Gregor Jul 1977 A
4142526 Zaffaroni et al. Mar 1979 A
4188817 Steigelmann Feb 1980 A
4192750 Elfes et al. Mar 1980 A
4193780 Cotton, Jr. et al. Mar 1980 A
4203848 Grandine, II May 1980 A
4218324 Hartmann et al. Aug 1980 A
4230583 Chiolle et al. Oct 1980 A
4247498 Castro Jan 1981 A
4248648 Kopp Feb 1981 A
4253936 Leysen et al. Mar 1981 A
4278548 Bettinger et al. Jul 1981 A
4302336 Kawaguchi et al. Nov 1981 A
4340479 Pall Jul 1982 A
4353802 Hara et al. Oct 1982 A
4354443 Abrahamson Oct 1982 A
4384474 Kowalski May 1983 A
4385150 Miyake et al. May 1983 A
4388189 Kawaguchi et al. Jun 1983 A
4407975 Yamaguchi Oct 1983 A
4431545 Pall et al. Feb 1984 A
4439217 Yamabe et al. Mar 1984 A
4451369 Sekino et al. May 1984 A
4511471 Müller Apr 1985 A
4519909 Castro May 1985 A
4540490 Shibata et al. Sep 1985 A
4547289 Okano et al. Oct 1985 A
4559139 Uemura et al. Dec 1985 A
4609465 Miller Sep 1986 A
4614109 Hofmann Sep 1986 A
4618533 Steuck Oct 1986 A
4623670 Mutoh et al. Nov 1986 A
4623690 Patzschke et al. Nov 1986 A
4629563 Wrasidlo Dec 1986 A
4632745 Giuffrida et al. Dec 1986 A
4636296 Kunz Jan 1987 A
4642182 Drori Feb 1987 A
4647377 Miura Mar 1987 A
4650586 Ellis, III Mar 1987 A
4650596 Schlueter et al. Mar 1987 A
4656865 Callan Apr 1987 A
4660411 Reid Apr 1987 A
4670145 Edwards Jun 1987 A
4673507 Brown Jun 1987 A
4687561 Kunz Aug 1987 A
4688511 Gerlach et al. Aug 1987 A
4695592 Itoh et al. Sep 1987 A
4702836 Mutoh et al. Oct 1987 A
4702840 Degen et al. Oct 1987 A
4707266 Degen et al. Nov 1987 A
4708799 Gerlach et al. Nov 1987 A
4718270 Storr Jan 1988 A
4735261 Huebner Apr 1988 A
4737425 Lin et al. Apr 1988 A
4744240 Reichelt May 1988 A
4756875 Tajima et al. Jul 1988 A
4758251 Swedo et al. Jul 1988 A
4763612 Iwanami Aug 1988 A
4767539 Ford Aug 1988 A
4775471 Nagai et al. Oct 1988 A
4779448 Gogins Oct 1988 A
4784771 Wathen et al. Nov 1988 A
4793932 Ford et al. Dec 1988 A
4797187 Davis et al. Jan 1989 A
4797211 Ehrfeld et al. Jan 1989 A
4810384 Fabre Mar 1989 A
4812235 Seleman et al. Mar 1989 A
4812269 Harttig et al. Mar 1989 A
4816160 Ford et al. Mar 1989 A
4840227 Schmidt Jun 1989 A
4846970 Bertelsen et al. Jul 1989 A
4849106 Mir Jul 1989 A
4855163 Joffee et al. Aug 1989 A
4876006 Ohkubo et al. Oct 1989 A
4876012 Kopp et al. Oct 1989 A
4886601 Iwatsuka et al. Dec 1989 A
4886668 Haslam et al. Dec 1989 A
4888115 Marinaccio et al. Dec 1989 A
4892739 Shah et al. Jan 1990 A
4904426 Lundgard et al. Feb 1990 A
4909943 Fibiger et al. Mar 1990 A
4921610 Ford et al. May 1990 A
4931186 Ford et al. Jun 1990 A
4935143 Kopp et al. Jun 1990 A
4963304 Im et al. Oct 1990 A
4968733 Muller et al. Nov 1990 A
4999038 Lundberg Mar 1991 A
5005430 Kibler et al. Apr 1991 A
5015275 Beck et al. May 1991 A
5017292 DiLeo et al. May 1991 A
5019260 Gsell et al. May 1991 A
5024762 Ford et al. Jun 1991 A
5032282 Linder et al. Jul 1991 A
5043113 Kafchinski et al. Aug 1991 A
5049275 Gillberg-LaForce et al. Sep 1991 A
5066375 Parsi et al. Nov 1991 A
5066401 Müller et al. Nov 1991 A
5066402 Anselme et al. Nov 1991 A
5069065 Sprunt et al. Dec 1991 A
5075065 Effenberger et al. Dec 1991 A
5076925 Roesink et al. Dec 1991 A
5079272 Allegrezza et al. Jan 1992 A
5094750 Kopp et al. Mar 1992 A
5104535 Cote et al. Apr 1992 A
5104546 Filson et al. Apr 1992 A
H1045 Wilson May 1992 H
5135663 Newberth, III et al. Aug 1992 A
5137631 Eckman et al. Aug 1992 A
5137633 Wang Aug 1992 A
5138870 Lyssy Aug 1992 A
5147553 Waite Sep 1992 A
5151189 Hu et al. Sep 1992 A
5151191 Sunaoka et al. Sep 1992 A
5151193 Grobe et al. Sep 1992 A
5158721 Allegrezza, Jr. et al. Oct 1992 A
5182019 Cote et al. Jan 1993 A
5192456 Ishida et al. Mar 1993 A
5192478 Caskey Mar 1993 A
5194149 Selbie et al. Mar 1993 A
5198116 Comstock et al. Mar 1993 A
5198162 Park et al. Mar 1993 A
5209852 Sunaoka et al. May 1993 A
5211823 Giuffrida et al. May 1993 A
5221478 Dhingra et al. Jun 1993 A
5227063 Langerak et al. Jul 1993 A
5248424 Cote et al. Sep 1993 A
5275766 Gadkaree et al. Jan 1994 A
5277812 Hu et al. Jan 1994 A
5282971 Degen et al. Feb 1994 A
5286324 Kawai et al. Feb 1994 A
5288324 Shaneyfelt Feb 1994 A
5297420 Gilliland et al. Mar 1994 A
5320760 Freund et al. Jun 1994 A
5353630 Soda et al. Oct 1994 A
5354587 Abayasekara Oct 1994 A
5361625 Ylvisaker Nov 1994 A
5364527 Zimmermann et al. Nov 1994 A
5376274 Muller et al. Dec 1994 A
5389260 Hemp et al. Feb 1995 A
5396019 Sartori et al. Mar 1995 A
5401401 Hickok et al. Mar 1995 A
5403479 Smith et al. Apr 1995 A
5403483 Hayashida et al. Apr 1995 A
5405528 Selbie et al. Apr 1995 A
5411663 Johnson May 1995 A
5417101 Weich May 1995 A
5419816 Sampson et al. May 1995 A
5451317 Ishida et al. Sep 1995 A
5470469 Eckman Nov 1995 A
5477731 Mouton Dec 1995 A
5479590 Lin Dec 1995 A
5480553 Yamamori et al. Jan 1996 A
5491023 Tsai et al. Feb 1996 A
5525220 Yagi et al. Jun 1996 A
5531848 Brinda et al. Jul 1996 A
5531900 Raghavan et al. Jul 1996 A
5543002 Brinda et al. Aug 1996 A
5543465 Bell et al. Aug 1996 A
5547575 Demmer et al. Aug 1996 A
5554283 Brinda et al. Sep 1996 A
5607593 Cote et al. Mar 1997 A
5629084 Moya May 1997 A
5639373 Mahendran et al. Jun 1997 A
5643455 Kopp et al. Jul 1997 A
5647988 Kawanishi et al. Jul 1997 A
5725769 Miller et al. Mar 1998 A
5747605 Breant et al. May 1998 A
D396046 Scheel et al. Jul 1998 S
D396477 Sadr Jul 1998 S
5783083 Henshaw et al. Jul 1998 A
D396726 Sadr et al. Aug 1998 S
D400890 Gambardella Nov 1998 S
5871823 Anders et al. Feb 1999 A
5906742 Wang et al. May 1999 A
5910250 Mahendran et al. Jun 1999 A
5914039 Mahendran et al. Jun 1999 A
5918264 Drummond et al. Jun 1999 A
5942113 Morimura Aug 1999 A
5944997 Pedersen et al. Aug 1999 A
5958243 Lawrence et al. Sep 1999 A
5981614 Adiletta Nov 1999 A
5988400 Karachevtcev et al. Nov 1999 A
6024872 Mahendran et al. Feb 2000 A
6039872 Wu et al. Mar 2000 A
6042677 Mahendran et al. Mar 2000 A
6045698 Cöté et al. Apr 2000 A
6045899 Wang et al. Apr 2000 A
6048454 Jenkins Apr 2000 A
6056903 Greenwood et al. May 2000 A
6074718 Puglia et al. Jun 2000 A
6077435 Beck et al. Jun 2000 A
6083393 Wu et al. Jul 2000 A
6096213 Radovanovic et al. Aug 2000 A
6113794 Kumara et al. Sep 2000 A
6146747 Wang et al. Nov 2000 A
6156200 Zha et al. Dec 2000 A
6159369 Strohm et al. Dec 2000 A
6159373 Beck et al. Dec 2000 A
6193890 Pedersen et al. Feb 2001 B1
6202475 Selbie et al. Mar 2001 B1
6214231 Cote et al. Apr 2001 B1
6221247 Nemser et al. Apr 2001 B1
6245239 Cote et al. Jun 2001 B1
6254773 Biltoft Jul 2001 B1
6264839 Mohr et al. Jul 2001 B1
6277512 Hamrock et al. Aug 2001 B1
6280626 Miyashita et al. Aug 2001 B1
6284135 Ookata Sep 2001 B1
6294039 Mahendran et al. Sep 2001 B1
6299773 Takamura et al. Oct 2001 B1
6315895 Summerton et al. Nov 2001 B1
6322703 Taniguchi et al. Nov 2001 B1
6325928 Pedersen et al. Dec 2001 B1
6337018 Mickols Jan 2002 B1
RE37549 Mahendran et al. Feb 2002 E
6354444 Mahendran Mar 2002 B1
6375848 Cote et al. Apr 2002 B1
6423784 Hamrock et al. Jul 2002 B1
6440303 Spriegel Aug 2002 B2
D462699 Johnson et al. Sep 2002 S
6448062 Huth et al. Sep 2002 B1
6465748 Yamanashi et al. Oct 2002 B2
6491165 Kuske Dec 2002 B2
6495041 Taniguchi et al. Dec 2002 B2
6524481 Zha et al. Feb 2003 B2
6550747 Rabie et al. Apr 2003 B2
6555005 Zha et al. Apr 2003 B1
6565748 Wang et al. May 2003 B1
6582603 Suzuki et al. Jun 2003 B1
6595167 Kaesgen Jul 2003 B2
6596167 Ji et al. Jul 2003 B2
D478913 Johnson et al. Aug 2003 S
6602391 Serikov Aug 2003 B2
6620319 Behmann et al. Sep 2003 B2
6635104 Komkova et al. Oct 2003 B2
6635179 Summerton et al. Oct 2003 B1
6641733 Zha et al. Nov 2003 B2
6645374 Cote et al. Nov 2003 B2
6656356 Gungerich et al. Dec 2003 B2
6682652 Mahendran et al. Jan 2004 B2
6685832 Mahendran et al. Feb 2004 B2
6699611 Kim et al. Mar 2004 B2
6705465 Ling et al. Mar 2004 B2
6721529 Chen et al. Apr 2004 B2
6723246 Krulik Apr 2004 B2
6723758 Stone et al. Apr 2004 B2
6727305 Pavez Aranguiz Apr 2004 B1
6761013 Tippey Jul 2004 B2
6770202 Kidd et al. Aug 2004 B1
6783008 Zha et al. Aug 2004 B2
6790912 Blong Sep 2004 B2
6793820 McCray et al. Sep 2004 B1
6811696 Wang et al. Nov 2004 B2
6821420 Zha et al. Nov 2004 B2
6830782 Kanazawa Dec 2004 B2
6851259 Simburger et al. Feb 2005 B2
6861466 Dadalas et al. Mar 2005 B2
6872305 Johnson et al. Mar 2005 B2
6884350 Muller Apr 2005 B2
6884375 Wang et al. Apr 2005 B2
6890435 Ji et al. May 2005 B2
6890645 Disse et al. May 2005 B2
6893568 Janson et al. May 2005 B1
6965033 Jiang et al. Nov 2005 B2
6969465 Zha et al. Nov 2005 B2
6974554 Cox et al. Dec 2005 B2
6994867 Hossainy et al. Feb 2006 B1
7000764 Otsubo Feb 2006 B2
7041728 Zipplies et al. May 2006 B2
7067058 Yeh et al. Jun 2006 B2
7070909 Japp et al. Jul 2006 B2
7128768 Liu et al. Oct 2006 B2
7226541 Muller et al. Jun 2007 B2
7229712 Eshraghi et al. Jun 2007 B2
7247238 Mullette et al. Jul 2007 B2
7300022 Muller Nov 2007 B2
7390418 Martin et al. Jun 2008 B2
7395646 Salman Jul 2008 B2
7404896 Muller Jul 2008 B2
7449112 Lee et al. Nov 2008 B2
7459085 Koguma et al. Dec 2008 B2
7537718 Mezhirov et al. May 2009 B2
7632439 Mullette et al. Dec 2009 B2
7648034 Charkoudian et al. Jan 2010 B2
7662212 Mullette et al. Feb 2010 B2
7819956 Muller Oct 2010 B2
7867417 Mullette Jan 2011 B2
20020104439 Komkova et al. Aug 2002 A1
20020148767 Johnson et al. Oct 2002 A1
20030065302 Kuroda Apr 2003 A1
20030073970 Suga Apr 2003 A1
20030178365 Zha et al. Sep 2003 A1
20030226797 Phelps Dec 2003 A1
20040084369 Zha et al. May 2004 A1
20040085300 Matusis May 2004 A1
20040092901 Reece et al. May 2004 A1
20040145076 Zha et al. Jul 2004 A1
20040167490 Nelson et al. Aug 2004 A1
20040167493 Jarpenberg Aug 2004 A1
20040168947 McDonald Sep 2004 A1
20040172002 Nelson Sep 2004 A1
20040176735 Snell Sep 2004 A1
20040195172 Yeh et al. Oct 2004 A1
20040217053 Zha et al. Nov 2004 A1
20050015052 Klippen Jan 2005 A1
20050029185 Muller Feb 2005 A1
20050032982 Muller Feb 2005 A1
20050035065 Martin Feb 2005 A1
20050098494 Mullette et al. May 2005 A1
20050218069 Lee et al. Oct 2005 A1
20060157404 Mullette et al. Jul 2006 A1
20060178480 Tada et al. Aug 2006 A1
20060228483 Abidine Oct 2006 A1
20060237038 Jetten et al. Oct 2006 A1
20070007197 Mahendran et al. Jan 2007 A1
20070107884 Sirkar et al. May 2007 A1
20080203018 Muller et al. Aug 2008 A1
20080214687 Muller et al. Sep 2008 A1
20100000942 Muller et al. Jan 2010 A1
20100119815 Kim May 2010 A1
20100213117 Mullette et al. Aug 2010 A1
20110147308 Johnston-Hall et al. Jun 2011 A1
Foreign Referenced Citations (159)
Number Date Country
897069 Apr 1972 CA
2207893 Dec 1997 CA
2428457 May 2002 CA
2440961 Sep 2002 CA
1159770 Sep 1997 CN
1552507 Dec 2004 CN
3904544 Aug 1990 DE
4007383 Sep 1991 DE
4117281 Jan 1992 DE
4113420 Oct 1992 DE
4117422 Nov 1992 DE
19503060 Aug 1996 DE
29906389 Jun 1999 DE
012557 Feb 1983 EP
050447 Oct 1985 EP
229019 Jul 1987 EP
250337 Dec 1987 EP
261734 Mar 1988 EP
0341151 Nov 1989 EP
407900 Jan 1991 EP
419396 Mar 1991 EP
463627 Jan 1992 EP
492942 Jul 1992 EP
509663 Oct 1992 EP
550798 Jul 1993 EP
395133 Feb 1995 EP
492446 Nov 1995 EP
430082 Jun 1996 EP
581168 Oct 1996 EP
763758 Mar 1997 EP
0772488 May 1997 EP
911073 Apr 1999 EP
920904 Jun 1999 EP
1034835 Sep 2000 EP
1052012 Nov 2000 EP
1236503 Aug 2004 EP
2620712 Mar 1989 FR
2674448 Oct 1992 FR
2850297 Jul 2004 FR
702911 Jan 1954 GB
2253572 Sep 1992 GB
2390042 Dec 2003 GB
53-028083 Mar 1978 JP
53-28083 Mar 1978 JP
55-129155 Jun 1980 JP
58-088007 May 1983 JP
60260628 Dec 1985 JP
60260628 Dec 1985 JP
61-097006 May 1986 JP
61-107905 May 1986 JP
61-192309 Aug 1986 JP
61-257203 Nov 1986 JP
61-263605 Nov 1986 JP
62-004408 Jan 1987 JP
62068828 Mar 1987 JP
62068828 Mar 1987 JP
62-114609 May 1987 JP
62-140607 Jun 1987 JP
62-179540 Aug 1987 JP
62-250908 Oct 1987 JP
63-097634 Apr 1988 JP
S63-38884 Oct 1988 JP
1075542 Mar 1989 JP
01075542 Mar 1989 JP
01-307409 Dec 1989 JP
2009498 Jan 1990 JP
02-031200 Feb 1990 JP
02-086822 Mar 1990 JP
02-144132 Jun 1990 JP
02-164423 Jun 1990 JP
02-284035 Nov 1990 JP
02302449 Dec 1990 JP
03-018373 Jan 1991 JP
03-110445 May 1991 JP
03-137927 Jun 1991 JP
03186325 Aug 1991 JP
04022428 Jan 1992 JP
04-187224 Jul 1992 JP
04-250898 Sep 1992 JP
04-265128 Sep 1992 JP
04293528 Oct 1992 JP
04300636 Oct 1992 JP
04-310223 Nov 1992 JP
05-023557 Feb 1993 JP
05-096136 Apr 1993 JP
05-96140 Apr 1993 JP
05-131124 May 1993 JP
05115760 May 1993 JP
05-157654 Jun 1993 JP
05-285348 Nov 1993 JP
06-071120 Mar 1994 JP
06-087935 Mar 1994 JP
06-114240 Apr 1994 JP
06027215 Apr 1994 JP
06-218237 Aug 1994 JP
06-285496 Oct 1994 JP
06-343837 Dec 1994 JP
07-000770 Jan 1995 JP
07-024272 Jan 1995 JP
07003043 Jan 1995 JP
07-155758 Jun 1995 JP
07155570 Jun 1995 JP
07-185268 Jul 1995 JP
07-185271 Jul 1995 JP
07-275665 Oct 1995 JP
08-010585 Jan 1996 JP
08052331 Feb 1996 JP
09-141063 Jun 1997 JP
09-220569 Aug 1997 JP
09-324067 Dec 1997 JP
09-512857 Dec 1997 JP
09512857 Dec 1997 JP
10-060142 Mar 1998 JP
10-156149 Jun 1998 JP
11-165200 Jun 1999 JP
11152366 Jun 1999 JP
11302438 Nov 1999 JP
11302438 Nov 1999 JP
2000-342932 Dec 2002 JP
2004230280 Aug 2004 JP
2004230280 Aug 2004 JP
2004523338 Aug 2004 JP
2005-514517 May 2005 JP
2005154551 Jun 2005 JP
2005-528213 Sep 2005 JP
2005-537120 Dec 2005 JP
2006517469 Jul 2006 JP
2002031017 Jul 2002 KR
2002061017 Jul 2002 KR
WO 88-06200 Aug 1988 WO
WO 90-00434 Jan 1990 WO
9117204 Nov 1991 WO
WO 93-02779 Feb 1993 WO
WO 93-15827 Aug 1993 WO
WO 95-34424 Dec 1995 WO
9603202 Feb 1996 WO
WO 96-07470 Mar 1996 WO
9614913 May 1996 WO
WO 96-41676 Dec 1996 WO
WO 98-22204 May 1998 WO
WO 98-25694 Jun 1998 WO
WO 98-28066 Jul 1998 WO
WO 99-01207 Jan 1999 WO
WO 0043115 Jul 2000 WO
WO 0238256 May 2002 WO
02087734 Nov 2002 WO
WO03068374 Aug 2003 WO
WO 03080228 Oct 2003 WO
03095078 Nov 2003 WO
WO 2004078327 Sep 2004 WO
WO 2004094049 Nov 2004 WO
2005005028 Jan 2005 WO
WO 2005002712 Jan 2005 WO
WO 2005030916 Apr 2005 WO
2006002479 Jan 2006 WO
2006058384 Jun 2006 WO
2006058394 Aug 2006 WO
2007006104 Jan 2007 WO
2007035987 Apr 2007 WO
Non-Patent Literature Citations (64)
Entry
English Language Machine Translation JP 06-027215 B.
English Language Machine Translation JP 2004-230280 A.
International Search Report dated Sep. 30, 2005 for Application No. PCT/AU2005/000975.
International Preliminary Report on Patentability dated Jun. 30, 2006 for Application No. PCT/AU2005/000975.
Extended European Search Report dated Mar. 3, 2009 for European Patent Application No. 0575700.
Almulla et al., Desalination, 153 (2002), pp. 237-243.
Anonymous, “Nonwoven Constructions of Dyneon™ THV and Dyneon™ The Fluorothermoplastics”, Research Disclosure Journal, Apr. 1999, RD 420013, 2 pages.
Hall, R. (1982) Peroxides and Peroxy Compounds, Inorganic, in Kirk-Othmer Encyclopedia of Chemical Technology, vol. 17, 3rd edition, John Wiley & Sons, p. 14-16.
Johnson, “Recent Advances in Microfiltration for Drinking Water Treatment,” AWWA Annual Conference, Jun. 20-24, 1999, Chicago, Illinois, entire publication.
Kaiya et al., “Water Purification Using Hollow Fiber Microfiltration Membranes,” 6th World Filtration Congress, Nagoya, 1993, pp. 813-816.
Kolthoff, I.M., et al., “The Chemistry of Persulfate—The Kinetics and Mechanism of the Decomposition of the Persulfate Ion in Aqueous Medium”, Journal of the American Chemical Society, Jul. 1951, vol. 73, pp. 3055-3059.
Lloyd, D.R. et al. “Microporous Membrane Formation via Thermally Induced Phase Separation/Solid-Liquid Phase Separation” Journal of Membrane Science (Sep. 15, 1990), pp. 239-261, vol. 52, No. 3, Elsevier Scientific Publishing Company, Amsterdam, NL.
Lozier et al., “Demonstration Testing of ZenoGem and Reverse Osmosis for Indirect Potable Reuse Final Technical Report,” published by CH2M Hill, available from the National Technical Information Service, Operations Division, Jan. 2000, entire publication.
Ramaswammy S. et al. “Fabrication of Ply (ECTFE) Membranes via thermally induced phase Separation”, Journal of Membrane Science, (Dec. 1, 2002), pp. 175-180, vol. 210 No. I, Scientific Publishing Company, Amsterdam, NL.
Rosenberger et al., Desalination, 151 (2002), pp. 195-200.
Ueda et al., “Effects of Aeration on Suction Pressure in a Submerged Membrane Bioreactor,” Wat. Res. vol. 31, No. 3, 1997, pp. 489-494.
White et al.,The Chemical Engineering Journal, 52 (1993), pp. 73-77.
Zenon, “Proposal for ZeeWeed® Membrane Filtration Equipment System for the City of Westminster, Colorado, Proposal No. 479-99,” Mar. 2000, entire publication.
Dupont Oxone Monopersulfate Compound, product literature (2008) pp. 1-3. http://ww2.dupont.com/Oxone/en—US/assets/downloads/K20101%20Oxone%20General%20Info.pdf.
International Search Report dated Sep. 13, 2005 for PCT Application No. PCT/AU2005/000961.
International Search Report dated Aug. 16, 2006 for Application No. PCT/AU2006/000997.
International Preliminary Report on Patentability dated Jun. 8, 2007 for Application No. PCT/AU2006/000997.
Supplementary EP Search Report dated Jun. 25, 2007 for European Application No. EP 05 75 6970.
International Preliminary Report on Patentability dated Jul. 12, 2006 for Application No. PCT/AU2006/000864.
International Preliminary Report on Patentability dated Feb. 10, 2006 for Application No. PCT/AU2005/001820.
Australian First Examiner's Report dated Nov. 10, 2009 for Application No. 2005259840.
Canadian Office Action dated Feb. 28, 2012 for Application No. 2,530,805.
Canadian Office Action dated Jun. 19, 2012 for Application No. 2,571,502.
Chinese Office Action dated Mar. 6, 2012 for counterpart Chinese Application 200480019288.1 (with translation).
Japanese Office Action dated Sep. 13, 2011 for Application No. 2007-518412 (with translation).
Notification of Transmittal of the International Search Report and the Written Opinion dated Jan. 17, 2012 for International Application No. PCT/US2011/052110.
PCT International Search Report Aug. 21, 2007 for corresponding Application No. PCT/AU2007/000979.
PCT International Search Report on Patentability dated Jan. 14, 2009 for corresponding Application No. PCT/AU2007/000979.
PCT International Search Report mailed Feb. 29, 2011 corresponding to PCT International Application No. PCT/US10/61245 filed Dec. 20, 2010 (11 pages).
Zeman et al., “Microfiltration and Ultrafiltration Principles and Practice,” (1996) ISBN 0-8247-9735-3, pp. 144-145 and 167.
Bao, Zhu, Chen, Xu and Xu, Progresses of Hydrophilic Modification and Functionalization of Poly(vinylidene fluoride) Porous Membranes, Journal of Functional Polymers, vol. 16, No. 2, pp. 269-270, Jun. 2003, Institute of Polymer Science, Zhejiang University.
Chinese Office Action dated Dec. 24, 2010 for counterpart Chinese Application 200480019288.1.
Chinese Office Action dated Oct. 30, 2009 for counterpart Chinese Application 200480019288.1.
English Translation of Office Action for Japanese Application No. 2006-517906.
European Search Report for European Application No. 0229019 A3, dated Nov. 11, 1988.
International Preliminary Report on Patentability dated Oct. 31, 2006 for Application No. PCT/AU2005/001820.
International Preliminary Report on Patentability dated Sep. 28, 2007 for Application No. PCT/AU2006/000864.
International Search Report dated Jul. 12, 2006 for Application No. PCT/AU2006/000864.
International Search Report dated Sep. 17, 2004 for PCT/AU2004/000922.
Written Opinion of the International Searching Authority dated Feb. 7, 2006 for Application No. PCT/AU2005/001820.
Written Opinion of the International Searching Authority dated Jul. 7, 2006 for Application No. PCT/AU2006/000864.
European Examination Report for Application No. 04737543.1 dated Nov. 9, 2010.
Australian Examiner's Report dated Feb. 18, 2011 for Application No. 2006261581.
Canadian Office Action dated Mar. 10, 2011 for Application No. 2,530,805.
European Examination Report for Application No. 04737543.1, dated Nov. 9, 2010.
Japanese Office Action dated Mar. 8, 2011 for Application No. 2008-517272.
Japanese Office Action dated Nov. 24, 2010 for Application No. 2008-520681.
New Zealand Examination Report dated Feb. 23, 2011 for Application No. 563980.
New Zealand Examination Report dated Oct. 16, 2009 from Application No. 563980.
Written Opinion of the International Searching Authority dated Aug. 16, 2006 for Application No. PCT/AU2006/000997.
Bhardwaj et al., Polysulfone Hollow Fibre Gas Separation Membranes filled with submicron particles; Annals of the New York Academy of Sciences; Mar. 2003, vol. 984, Advanced Membrane Technology, pp. 318-328.
Wharry, Jr., “Fluropolymer Heat Exchangers,” Metal Finishing vol. 99, Supplement 1, Jan. 2001, pp. 760-777.
Zaheed et al., “Review of polymer compact heat exchangers, with special emphasis on a polymer film unit,” Journal of Applied Thermal Engineering, 2004, vol. 24, pp. 2323-2358.
Ebewele et al.,“Polymer Science and Technology,” p. 445.
Houghman et al, “Fluoropolymers: Synthesis,” p. 92.
Smolders et al., “Liquid-liquid phase separation in concentrated solutions of non-crystallizable polymers by spinodal decomposition,” Kolloid-Z. u. Polymere, 243, 14-20 (1971).
Supplementary EP Search Report dated Apr. 15, 2010 for European Application No. EP 06 74 1265.
Supplementary EP Search Report dated Nov. 25, 2009 for European Application No. EP 06 76 0859.
Chinese Office Action dated Apr. 21, 2010 for Chinese Application No. 200680022006.2.
Related Publications (1)
Number Date Country
20080058440 A1 Mar 2008 US